HomeToday’s HighlightsThe Amgen/Novartis story. A Little Curiosity About Alder Biopharmaceuticals. The Amgen/Novartis story. A Little Curiosity About Alder Biopharmaceuticals. Today’s Highlights April 8, 2019 The Amgen/Novartis Story In May 2018 Amgen (AMGN) & Novartis (This content is for paid subscribers. Please click here to subscribe or here to log in. Today’s Highlights Alder BioPharmaceuticals (ALDR), Amgen (AMGN), Novartis (NVS) April 8, 2019 Tweet Pin It Other Articles Precigen Announces Full FDA Approval of PAPZIMEOS, the Only Currently Approved Treatment for Adults with Recurrent Respiratory Papillomatosis August 15, 2025 0 Approval of BRINSUPRI™ for the Treatment of Non-Cystic Fibrosis Bronchiectasis August 13, 2025 0 How Alnylam Pharmaceuticals Made Our Day Today and More July 31, 2025 0 GSK Announces the Linked by Lupus: Optimal Care Initiative to Help Support Individuals with Lupus in the US July 28, 2025 0